Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
Background
Cited by
Items 601–700 of 905
Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
Luo, H.-Y., Cao, L., Zhou, K., Xiao, Y., Li, Z., Liu, B., & Bu, L. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.08.001 · Cited by 6
Repurposing the bacterial surface display technology for drug delivery
Yang, S., Yang, M., Jennings, M., Timek, H., Haley, A. E., Romee, R., & Li, J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115701 · Cited by 10
Engineering smart bacteria for the next generation
Qiao, L., Wang, Z., Tang, S., Tian, J., Ye, H., & Cai, F. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102681 · Cited by 12
“10 To address this, synthetic biology-driven remote control systems have been developed, which integrate synthetic genetic circuits to regulate transgene expression in response to chemical inducers, 11 physical signals (e.g., heat 12 and light 13 ), or disease-specific biomarkers.”
Surface Modification of Bacteria to Optimize Immunomodulation for Advanced Immunotherapy
Xue, K., Wang, L., & Liu, J. (2022) · ChemMedChem · doi:10.1002/cmdc.202200574 · Cited by 6
Naseri, G., Raasch, H., Charpentier, E., & Erhardt, M. (2023) · Communications Biology · doi:10.1038/s42003-023-05363-3 · Cited by 6
Nanobiohybrids and bacterial carriers: a novel pathway to targeted cancer therapy
Ali, D. S., Othman, H. O., Mohammed, S. H., Hassan, R. O., Faethullah, Z. S., Kareem, R. I., & Smaoui, S. (2024) · Nano Futures · doi:10.1088/2399-1984/ad7802 · Cited by 7
“For example, facultative anaerobic bacteria E. coli and Sjson typhimurium would have followed the sense of the chemoreceptors to perceive the favorable nutrient-rich environment and accumulated them consequently both at the core and peripheral regions of the tumor (Forbes 2010).”
Human Commensal Bacteria: Next-generation Pro- and Post-biotics for Anticancer Therapy
Sapkota, H., Dasgupta, S., Roy, B., & Pathan, E. K. (2025) · Frontiers in Bioscience-Elite · doi:10.31083/fbe26809 · Cited by 12
“Gram-negative bacteria ( Salmonella , Escherichia , Pseudomonas , and Pro-teus ) and gram-positive bacteria ( Clostridium , Bifidobacterium , and Lactobacillus ) have been reported to have cytotoxic, antiproliferative and apoptotic effects on cancer cells [24,32].”
Hamza, M., Wang, S., Liu, Y., Li, K., Zhu, M., & Chen, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128156 · Cited by 6
Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth
Lee, C., Nishikawa, T., & Kaneda, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17037 · Cited by 6
Mukai, H., Takahashi, M., & Watanabe, Y. (2017) · Cancer Gene Therapy · doi:10.1038/s41417-017-0009-7 · Cited by 6
Microbes in Oncology: Controllable Strategies for Bacteria Therapy
Du, M., Yu, J., Yang, Y., Yan, F., & Chen, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0025 · Cited by 8
“However, these same characteristics of tumor microenvironments provide appropriate conditions for some bacteria to colonize, proliferate, or even develop anti-tumor abilities [3].”
BackgroundRedesign of ultrasensitive and robust RecA gene circuit to sense DNA damage
Chen, J. X., Lim, B., Steel, H., Song, Y., Ji, M., & Huang, W. E. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13767 · Cited by 8
“Despite advancements in treating gut inflammation (Forbes, 2010; Archer et al., 2012; Kurtz et al., 2019), hyperammonemia (Kurtz et al., 2019), obesity (Chen et al., 2014) and various cancer treatments (Ganai et al., 2009; He et al., 2017; Yu et al., 2019), bacterial therapy still lacks accurate…”
L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review
Sindhu, R., & Manonmani, H. K. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220106103336 · Cited by 6
Study of the influence of sensor permeability in the detection of a single magnetotactic bacterium
de Cos, D., Lete, N., Fdez-Gubieda, M. L., & García-Arribas, A. (2019) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2019.166346 · Cited by 6
Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm
Dalal, P., & Sharma, D. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab116 · Cited by 6
Genetically Engineered Salmonella typhimurium for Targeted Cancer Therapy
Kwon, S., & Min, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00030-5 · Cited by 7
Magnetic torque-driven living microrobots for enhanced tumor infiltrationPreprint
Gwisai, T., Mirkhani, N., Christiansen, M. G., Nguyen, T. T., Ling, V., & Schuerle, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.03.473989 · Cited by 6
Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects
Han, M., Kim, E., Jeong, M., Kim, S., Lee, H. J., & Jeon, H. J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.025 · Cited by 5
Han, C., Li, J., Qiao, X., Wang, M., Yang, L., Zhang, X., Bao, F., Qiao, L., Jin, Y., Li, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113863 · Cited by 5
Glutathione-responsive self-assembling peptide-coated Salmonella for antitumor therapy
Shen, J., Yongjie, Z., Li, T., Wu, X., Zheng, J. H., & Shi, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114547 · Cited by 8
Emerging porous materials for cell encapsulation
Carraro, F., Velásquez-Hernández, M. D. J., Emmerstorfer‐Augustin, A., Kracher, D., Wu, Q., Kourist, R., Chou, L., Ge, J., Shieh, F., Doonan, C. J., et al. (2026) · Chemical Society Reviews · doi:10.1039/d4cs00071d · Cited by 5
Wu, S., Yang, W., Wu, Z., Liu, D., Liu, C. X., Cui, T., Wang, H., Yun, Y., Yu, Y., & Zhang, B. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c03081 · Cited by 5
Comparison of aggregation effect of axial and polar Magnetotactic bacteria for tumor therapy
Wang, Q., Chen, C., Chen, H., Wang, P., Jiao, Y., Guo, H., & Song, T. (2024) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2024.172038 · Cited by 5
Asaftei, M., Lucidi, M., Anton, S. R., Tranca, D. E., Hristu, R., Wu, A., Yang, Y., Stanciu, G. A., Lazăr, V., Ioniţă, M., et al. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.111962 · Cited by 5
Bacterial Autonomous Intelligent Microrobots for Biomedical Applications
Chen, H., Li, Y., Li, Z., Sun, Y., Gu, W., Chen, C., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70011 · Cited by 6
Investigating the Physical Effects in Bacterial Therapies for Avascular Tumors
Mascheroni, P., Meyer‐Hermann, M., & Hatzikirou, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01083 · Cited by 5
“The same hypoxic areas provide indeed a niche for bacteria to colonize the tumor and exert a therapeutic action (Forbes, 2010; Zhou et al., 2018).”
BackgroundInfluentialSimulation of flow past a squirmer confined in a channel at low Reynolds numbers
Li, S., Ying, Y., & Nie, D. (2023) · Fluid Dynamics Research · doi:10.1088/1873-7005/acfbb0 · Cited by 5
Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum
Lim, D., Kim, K., Duysak, T., So, E., Jeong, J., & Choy, H. E. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100745 · Cited by 5
Sutar, A., Dashpute, R. S., Shinde, Y. D., Mukherjee, S., & Chowdhury, C. (2023) · Indian Journal of Microbiology · doi:10.1007/s12088-023-01176-4 · Cited by 7
“Salmonella infection has been studied extensively as a potential tool to combat cancer [109].”
Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors
Huang, G., Tang, Z., Yin, T., Ma, A.-Q., Gong, H., Zhang, Y., Pan, H., & Cai, L. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102022 · Cited by 9
An Autonomous and Adaptive Bacteria-based Drug Delivery System
Lo, C., Bhardwaj, K., & Mărculescu, R. (2016) · ACM International Conference on Nanoscale Computing and Communication (NANOCOM) · doi:10.1145/2967446.2967458 · Cited by 5
“To handle both problems, a bacteria-based drug delivery system can be a perfect candidate; this is because bacteria can be engineered to navigate toward the target location and then deliver a precise amount of drugs in an adaptive fashion [2].”
BackgroundBacteria in Carcinogenesis and Cancer Prevention: A Review Study
Nokhandani, N., Poursheikhani, A., Alhosseini, M. N., & Davoodi, H. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.107956 · Cited by 6
“Additionally, bacteria can transfer some substances coupled with antitumor agents to the human body and destroy the cancerous cells (57).”
BackgroundZhao, Q. C., Wang, Y., & Li, W. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-4 · Cited by 5
“Since then, various bacterial strains had been investigated as anti-tumor agents (8).”
BackgroundSenevirathne, A., Hewawaduge, C., & Lee, J. H. (2021) · Veterinary Research · doi:10.1186/s13567-021-00995-x · Cited by 5
“These species are highly efficient in invading both phagocytic cells and nonphagocytic cells and preferentially populate hypoxic tumours [10, 11].”
BackgroundBacteriolytic therapy with Clostridium ghonii for experimental solid tumors
Wang, Y., Liu, Y., Zhu, H., Wang, D., Wang, S., Xu, X., Yu, N. H., Feng, J., Zou, J., Wang, X., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.106 · Cited by 7
Trojan nanobacteria hybridized with prodrug nanocapsules for efficient combined tumor therapy
Zang, M., Ji, Y., Ding, X., Xu, Z., Hou, J., Sun, J., Xu, J., Yu, S., Sun, H., Wang, T., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5503-7 · Cited by 6
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells
Menghini, S., Vizovišek, M., Enders, J., & Schuerle, S. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00313-3 · Cited by 6
“It is therefore not surprising that their suitability and significance as a novel tool for cancer therapy are becoming increasingly recognized [38].”
BackgroundKolewe, E. L., Swofford, C. A., & Forbes, N. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3515-4_4 · Cited by 5
“Therapeutic bacteria have many advantages over standard chemotherapeutic drugs because of their unique properties [2].”
BackgroundSelf-citationSuh, S., Leaman, E. J., Zhan, Y., & Behkam, B. (2018) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2018.8513596 · Cited by 5
“Some strains have shown tumor-selective localization and preferential colonization, and others have shown an invasive phenotype in tumor tissue and are capable of intratumoral penetration, which can enhance the interstitial transport efficacy [6], [7].”
BackgroundMagnetic Soft Robots for Targeted Bacterial Delivery and Enhanced Tumor Spheroid Disaggregation
Krauss, T., Yaşa, Ö., Pustovalov, V., Filippi, M., Pané, S., & Katzschmann, R. K. (2025) · Advanced Intelligent Systems · doi:10.1002/aisy.202500257 · Cited by 4
Materiomics approaches for stimuli-responsive microrobots
Orecchio, S., Arrabito, G., Pellerito, C., Fiore, T., Campanile, F., Meringolo, F., Costanzo, P., Fortuna, S. A., Barreca, S., Puleo, G., et al. (2025) · Journal of Materials Chemistry C · doi:10.1039/d5tc00342c · Cited by 4
Yao, S., Wang, S., Wang, Z., Hu, Q., Jiang, Z., Liu, Z., Cheng, Y.-Y., Wu, C., Wang, Z. L., & Li, L. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2024.100007 · Cited by 4
Zhang, B., Jin, R., Xie, X., Tan, L., Ma, M., Li, C., Zhao, Y., Wang, Q. A., Zou, J.-H., & Liu, B. (2025) · ACS Materials Letters · doi:10.1021/acsmaterialslett.5c00012 · Cited by 4
Microorganism delivery of cancer vaccines
Han, F., Yin, L., Qu, L., Han, S., Sun, M., & Yang, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114288 · Cited by 7
Mao, P., Wang, X., Peng, Y., Alves, M. D. S., Almeida, J. D., Liu, Y., Zhou, S., Zhao, Z., Su, L., Wang, X., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114781 · Cited by 5
Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
Yu, Y., Guo, Z., Luo, Z., Dian, Y., Yang, X., Chen, X., Zeng, F., & Deng, G. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00473-w · Cited by 5
“…enabled engineered bacteria to serve as multifaceted cancer therapeutics, owing to their low toxicity and ability to express prod-rug-converting enzymes, release cytotoxic molecules in a controlled manner, modulate immune responses, and target the tumor stroma to enhance antitumor efficacy [411].”
Kaur, T., & Sharma, D. (2023) · Advances in applied microbiology · doi:10.1016/bs.aambs.2023.03.001 · Cited by 4
kavianpour, A. H., Behbahani, M., & Mohabatkar, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106815 · Cited by 4
Personalised medicine based on host genetics and microbiota applied to colorectal cancer
González, A., Badiola, I., Fullaondo, A., Rodríguez, J., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.004 · Cited by 4
Yang, J., Yang, M., Wang, Q., Luo, Q., Wang, Y., Sun, J., Liu, J., Chen, J., Mao, J., Yin, H., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157034 · Cited by 5
Engineering immunity: bacterial delivery of cancer neoantigen vaccines
Johnston, C. D., & Wargo, J. A. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.007 · Cited by 5
Liang, C., Yang, H., Li, T., Jiang, X., Li, X., Gao, C., & Hou, L. (2025) · Advanced Science · doi:10.1002/advs.202414233 · Cited by 8
Bacterial Therapeutics: Addressing the Affordability Gap in Cancer Therapy
Prifti, K., Chabu, C. Y., Kobayashi, K. S., Song, J. J., Han, A., & de Figueiredo, P. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0870 · Cited by 4
Programming Biology: Expanding the Toolset for the Engineering of Transcription
Hove, B. V., Love, A. M., Ajikumar, P. K., & Mey, M. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-22708-5_1 · Cited by 4
Systems-synthetic biology in understanding the complexities and simple devices in immunology
Soni, B., Nimsarkar, P., Mol, M., Saha, B., & Singh, S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.029 · Cited by 4
Mapping Salmonella typhimurium pathways using 13C metabolic flux analysis
Correia, D. M., Sargo, C. R., da Silva, A. J., Santos, S., Giordano, R. C., Ferreira, E. C., Zangirolami, T. C., Ribeiro, M. P. D. A., & Rocha, I. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.11.011 · Cited by 4
“In addition, promising results have been obtained with the utilization of Salmonella in treatment and vaccination against non-infectious diseases, such as several types of cancer, including melanoma, and breast, prostate, pancreatic and cervix cancers (Bolhassani and Zahedifard, 2012; Forbes, 2010; Heimann and Rosenbe…”
ResultAntitumor Effect of Cycle Inhibiting Factor Expression in Colon Cancer via Salmonella VNP20009
Liu, L., Zhang, J., Gu, M., Li, G., Ni, J., & Fan, M. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200423080622 · Cited by 4
Elmanama, I. A., Elmanama, A. A., Zaharna, M. M., & Al-Reefi, M. R. (2020) · IUG Journal of Natural Studies · doi:10.33976//iugns.28.2/2020/2 · Cited by 4
“In recent studies they showed that they could control tumor growth (Forbes, 2010).”
BackgroundBiosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography
Nomura, S., Takahashi, M., Kato, A., Wada, Y., Watanabe, Y., Yamashita, F., & Mukai, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119950 · Cited by 4
Nomura, S., Sukowati, E. W., Shigeno, Y., Takahashi, M., Kato, A., Benno, Y., Yamashita, F., & Mukai, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030989 · Cited by 6
“In addition to using probiotics to improve gut function [2], the development of live bacterial therapeutics against cancer using a tumor-selective growth of injected anaerobic bacteria [3,4] is underway.”
BackgroundHybrid Bacteria System with Nanomaterials for Tumor Therapy
Zhang, Q., Ma, X., & Zhao, X. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300003 · Cited by 6
Bacterial Delivery of RNAi Effectors
Lage, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00005-6 · Cited by 4
Mushtaq, S., Choi, M. H., Yang, J. E., Shim, H. E., Song, L., Song, H. Y., Choi, Y. J., & Jeon, J. (2018) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-018-5941-y · Cited by 4
Virgile, C., Hauk, P., Wu, H., & Bentley, W. E. (2019) · Biotechnology Progress · doi:10.1002/btpr.2778 · Cited by 4
Huang, Y., Chu, C., Wu, C.-H., Chen, C., & Chiu, C.-H. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0078-y · Cited by 4
“Moreover, the bioluminescence vehicle can be genetically engineered to carry some other potential exogenous genes, such as anticancer agents for therapeutic purposes [31].”
BackgroundIsolation and Analysis of Suppressor Mutations in Tumor-Targeted msbB Salmonella
Low, K. B., Murray, S. R., Pawelek, J. M., & Bermudes, D. G. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3515-4_10 · Cited by 4
Başağaoğlu, H., Blount, J. L., Blount, J. L., Nelson, B., Sauro Succi, A., Westhart, P. M., & Harwell, J. R. (2016) · Computer Physics Communications · doi:10.1016/j.cpc.2016.12.012 · Cited by 4
Application of Bacterial Whole-Cell Biosensors in Health
Song, Y., Rampley, C. P. N., Chen, X., Du, F., Thompson, I. P., & Huang, W. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-47405-2_136-1 · Cited by 4
Tumor Pre-Targeting System Using Streptavidin-Expressing Bacteria
Kwon, S. E., You, S.-H., Im, J. H., Nguyen, D.-H., Kim, D., Pyo, A., Kim, G., Bom, H., Hong, Y., & Min, J. (2024) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01915-z · Cited by 3
“We believe that the strength of our study lies in the fact that tumor-targeting bacteria are very specific, can migrate to regions distant from the vasculature (which are hypoxic and resistant to conventional therapy), and replicate readily in tumor tissues [9, 27].”
Anaerobic bacterial metabolism responsive microspheres for bacterial embolization cancer therapy
Choi, H., Choi, B., & Kim, D. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122902 · Cited by 3
Zhao, B., Zhou, B., Li, Q., Su, C., Ma, J., & Yang, L. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.70006 · Cited by 3
Xu, H., Xiong, S., Zheng, D., An, L., Chen, Y., Wang, L., Rui, X., & Wu, J. (2025) · Nano Research · doi:10.26599/nr.2025.94907827 · Cited by 3
Chen, S., Ouyang, X., Wei, X., He, G., Xian, Y., Zhang, C., & Wu, D. (2025) · Biomaterials Science · doi:10.1039/d5bm00667h · Cited by 3
Rational engineering of combinatorial bacterial therapies for cancer
Steppe, P., O’Connor, K., & Hasty, J. (2026) · Genome biology · doi:10.1186/s13059-026-03951-0 · Cited by 6
Yu, Z., Wang, J., Qiao, Y., Wang, C., Yang, T., Tang, Y., Chen, L., Chen, H., & Wu, H. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04110-0 · Cited by 3
“Among them, the attenuated Salmonella typhimurium VNP20009, a facultative anaerobe with reduced toxicity, exhibits strong chemotaxis toward hypoxic tumor regions and flagella-driven motility that enables efficient penetration across physiological barriers [23, 25, 26].”
Polysaccharide-Based Encapsulation of Microbes for Enhanced Microbial Therapy
Wang, Y., Zhu, Z., Chen, M., & Liu, J. (2026) · Polymer science & technology. · doi:10.1021/polymscitech.5c00138 · Cited by 3
“Conventional cancer therapies face persistent challenges, 97 including poor specificity, systemic toxicity, and limited efficacy against an immunosuppressive tumor microenvironment.”
Stimulus-responsive engineered oncolytic bacteria
Chen, J., Liu, Y., Wu, Y., & Liu, Z. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124303 · Cited by 3
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
Chen, J., Bai, Y., Shen, L., Ying, J., Xu, J. Q., Tang, J., & Bao, Y.-J. (2026) · MedComm · doi:10.1002/mco2.70825 · Cited by 3
“When coupled with focal hemorrhage and altered interstitial pressure, these features facilitate the retention of blood-borne microorganisms within the tumor microvascular bed and enhance their extravasation into the stroma, thereby creating a relatively permissive colonization window [ 33, 77 ].”
Engineered microbe-based micro/nanorobots for interventional therapy of luminal cancers
Wang, L., Du, T., Ran, N., Kang, Y., & Ji, X. (2026) · Medicine Plus · doi:10.1016/j.medp.2026.100156 · Cited by 4
The Microbial Sources of Bioactive Compounds: Potential Anticancer Therapeutic Options
Ahmed, N., Abusalah, M. A. H., Absar, M. M., Nasir, M. H., Farzand, A., Ahmad, I., Sohail, Z., Singh, K. K. B., Baig, A. A., & Yean, C. Y. (2024) · Nano LIFE · doi:10.1142/s1793984424300073 · Cited by 8
Chaturvedi, R., Kang, Y., Eom, Y., Torati, S. R., & Kim, C. (2025) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2025.100873 · Cited by 3
Magnetic Micro- and Nanoagents for Monitoring Enzymatic Activity In Vivo
Christiansen, M. G., Vizovišek, M., & Schuerle, S. (2021) · Annual Review of Control Robotics and Autonomous Systems · doi:10.1146/annurev-control-042920-013605 · Cited by 3
Li, X., Chen, Y., Wang, R., Lu, E., Luo, K., & Sha, X. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123430 · Cited by 3
Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies
Gurbatri, C. R., & Danino, T. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3593-3_19 · Cited by 4
In vitro anti-tumor effects of hemocyanin isolated from Atergatis roseus and Eriphia verrucosa crabs
Salama, W. M., & Mona, M. M. (2018) · Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2019.34742 · Cited by 3
“Wong and Slavec (2015) found that bacteria is well suited to has antitumor effect due to its mobility through the anaerobic environment of tumor environment, cytoxicity, tumor specifity and therapeutic gene expression (Forbes, 2010), Salmonella (Leschner and Weiss 2010), Clostridium (Minton 2003), Bifidobacterium (Kim…”
BackgroundChugh, A., Bhatia, P., & Jain, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9514-2_16 · Cited by 5
Antimelanoma Effect of Salmonella Typhimurium Integration Host Factor Mutant in Murine Model
Werle, C. H., Damiani, I. A. C., Milanez, G. P., Farias, A. S., Gomes‐Marcondes, M. C. C., Culler, H. F., Sircili, M. P., Leite, B., & Brocchi, M. (2016) · Future Oncology · doi:10.2217/fon-2015-0062 · Cited by 3
A Geneticist’s View of Prostate Cancer: Prostate Cancer Treatment Considerations
Eisenstark, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95693-0_8 · Cited by 3
Maslowski, K. M., Takahashi, M., Nakanishi, Y., Mackie, G. M., Everard, I., Copland, A., Oda, H., Kanaya, T., & Ohno, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/741686 · Cited by 3
Menghini, S., Ho, P. S., Gwisai, T., & Schuerle, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.121574 · Cited by 2
Engineered bacteria recruit and orchestrate anti-tumor immunityPreprint
Savage, T. M., Vincent, R. L., Rae, S. S., Huang, L. H., Ahn, A., Pu, K., Li, F., Coker, C., Danino, T., & Arpaia, N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.496462 · Cited by 3
Colorectal cancer detection and treatment with engineered probioticsPreprint
Gurbatri, C. R., Radford, G., Vrbanac, L., Coker, C., Im, J., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K. Y., Saleh, A. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.03.535370 · Cited by 3
Goswami, G. R., Patil, R., Ghosh, S., Kaur, G., & Banerjee, A. G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4853291 · Cited by 3
Introduction to microbiomes in health and diseases
Agrawal, P., Mendhey, P., Kumar, R., Patel, S., Kaushik, P. K., Dadsena, A., & Kumar, S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.010 · Cited by 3
Bhamble, S., Kumar, K., Datta, P., Dighe, S., & Jain, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106665 · Cited by 4
Nano-immunotherapy: Merging immunotherapy precision with nanomaterial delivery
Hà, N. T. T., Menon, S., & Rivero‐Müller, A. (2025) · iScience · doi:10.1016/j.isci.2025.112319 · Cited by 4
“113 Additionally, other prokaryotes such as Listeria sp. have been shown to accumulate in heavily immune-suppressed tissues, such as tumors or metastases, while cleared from healthy tissues.”
Zhan, Y., Saha, B., Burkel, B. M., Leaman, E. J., Ponik, S. M., & Behkam, B. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00770-7 · Cited by 6
Park, J., Chang, S., Kang, H., Yi, S., Jang, I.-H., Lee, K.-A., Kim, D.-H., & Kim, J. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2503.07031 · Cited by 3
“Even when using attenuated or non-pathogenic strains, the risk of uncontrolled bacterial proliferation or systemic infection persists, especially in immunocompromised patients or individuals with disrupted mucosal barriers [16, 17].”
Probiotics lead to a new frontier in tumor fighting: tumor vaccines based on probiotics
Ma, T., Liang, Q., Zhou, Z., & Shen, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07426-x · Cited by 3
“This can be achieved through the design of genetic engineering strategies, the optimization of specific bio-synthetic pathways, and other innovative methods [13].”
Farmer, S., Francis, O., & Goyal, N. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04716-w · Cited by 4
“The concept of innate targeting relies on the natural tumor-colonizing ability of facultative and obligate anaerobes such as Salmonella typhimurium and Clostridium spp. , which preferentially accumulate in hypoxic and necrotic tumor cores where immune surveillance is compromised (Forbes 2010).”
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.